Treatment with myristicin and l-cycloserine in L6 myotubes prevented palmitate-mediated increase in intracellular ceramide content, increased Akt phosphorylation at Thr34, and attenuated palmitate-induced insulin resistance (Powell et al., 2004). This evidence concerns the gene AKT1 and Insulin resistance.